155 related articles for article (PubMed ID: 17127787)
1. Acute myeloid leukemia with severe aplastic anemia following immunosuppressive therapy.
Bakhshi S; Gupta A; Kumar L
Indian J Pediatr; 2006 Nov; 73(11):1033-5. PubMed ID: 17127787
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive therapy for patients with Down syndrome and idiopathic aplastic anemia.
Suzuki K; Muramatsu H; Okuno Y; Narita A; Hama A; Takahashi Y; Yoshida M; Horikoshi Y; Watanabe K; Kudo K; Kojima S
Int J Hematol; 2016 Jul; 104(1):130-3. PubMed ID: 27107757
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic stem cell transplantation for aplastic anemia and paroxysmal nocturnal hemoglobinuria: current evidence and recommendations.
Marotta S; Pagliuca S; Risitano AM
Expert Rev Hematol; 2014 Dec; 7(6):775-89. PubMed ID: 25331515
[TBL] [Abstract][Full Text] [Related]
4. Management of the refractory aplastic anemia patient: what are the options?
Marsh JC; Kulasekararaj AG
Hematology Am Soc Hematol Educ Program; 2013; 2013():87-94. PubMed ID: 24319168
[TBL] [Abstract][Full Text] [Related]
5. Donor bone marrow response to immunosuppressive treatment.
Arranz R; González N; Fernández-Garese D; Fernández-Rañada JM
Acta Haematol; 1988; 79(1):50-2. PubMed ID: 3124462
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of acquired aplastic anaemia in children: comparison between immunosuppressive therapy and bone marrow transplantation.
Kojima S; Horibe K; Inaba J; Yoshimi A; Takahashi Y; Kudo K; Kato K; Matsuyama T
Br J Haematol; 2000 Oct; 111(1):321-8. PubMed ID: 11091219
[TBL] [Abstract][Full Text] [Related]
7. Outcome of pediatric acquired aplastic anemia: a developing world experience.
Ramzan M; Yadav SP; Zafar MS; Dinand V; Sachdeva A
Pediatr Hematol Oncol; 2014 Feb; 31(1):29-38. PubMed ID: 23802844
[TBL] [Abstract][Full Text] [Related]
8. Practical aspects in the diagnosis and management of aplastic anemia.
Fonseca R; Tefferi A
Am J Med Sci; 1997 Mar; 313(3):159-69. PubMed ID: 9075433
[TBL] [Abstract][Full Text] [Related]
9. Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT).
Locasciulli A; Oneto R; Bacigalupo A; Socié G; Korthof E; Bekassy A; Schrezenmeier H; Passweg J; Führer M;
Haematologica; 2007 Jan; 92(1):11-8. PubMed ID: 17229630
[TBL] [Abstract][Full Text] [Related]
10. A retrospective analysis of long-term survival in severe aplastic anemia patients treated with allogeneic bone marrow transplantation or immunosuppressive therapy with antithymocyte globulin and cyclosporin A at a single institution.
Ellis RJ; Kahn Q; Skikne BS; Mayo MS; Allgood JW; Bodensteiner DM; Deauna-Limayo D; Cook JD
Mil Med; 2002 Jul; 167(7):541-5. PubMed ID: 12125844
[TBL] [Abstract][Full Text] [Related]
11. Acquired aplastic anemia in children: incidence, prognosis and treatment options.
Locasciulli A
Paediatr Drugs; 2002; 4(11):761-6. PubMed ID: 12390048
[TBL] [Abstract][Full Text] [Related]
12. Clinical results in 50 multiply transfused patients with severe aplastic anemia treated with bone marrow transplantation or immunosuppressive therapy.
Arranz R; Otero MJ; Ramos R; Steegmann JL; Lamana ML; Tomás JF; de la Cámara R; Figuera A; Vázquez L; Fernádez-Rañada JM
Bone Marrow Transplant; 1994 Apr; 13(4):383-7. PubMed ID: 8019461
[TBL] [Abstract][Full Text] [Related]
13. Comparison of long-term outcome of children with severe aplastic anemia treated with immunosuppression versus bone marrow transplantation.
Gillio AP; Boulad F; Small TN; Kernan NA; Reyes B; Childs BH; Brochstein JA; Laver J; Castro-Malaspina H; O'Reilly RJ
Biol Blood Marrow Transplant; 1997 Apr; 3(1):18-24. PubMed ID: 9209737
[TBL] [Abstract][Full Text] [Related]
14. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party.
Socié G; Henry-Amar M; Bacigalupo A; Hows J; Tichelli A; Ljungman P; McCann SR; Frickhofen N; Van't Veer-Korthof E; Gluckman E
N Engl J Med; 1993 Oct; 329(16):1152-7. PubMed ID: 8377778
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of severe acquired aplastic anemia].
Jacobsen N
Nord Med; 1995; 110(12):314-5. PubMed ID: 8524632
[TBL] [Abstract][Full Text] [Related]
16. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT.
Dufour C; Veys P; Carraro E; Bhatnagar N; Pillon M; Wynn R; Gibson B; Vora AJ; Steward CG; Ewins AM; Hough RE; de la Fuente J; Velangi M; Amrolia PJ; Skinner R; Bacigalupo A; Risitano AM; Socie G; Peffault de Latour R; Passweg J; Rovo A; Tichelli A; Schrezenmeier H; Hochsmann B; Bader P; van Biezen A; Aljurf MD; Kulasekararaj A; Marsh JC; Samarasinghe S
Br J Haematol; 2015 Nov; 171(4):585-94. PubMed ID: 26223288
[TBL] [Abstract][Full Text] [Related]
17. [Second allogenic bone marrow transplantation after late graft rejection in a patient with severe aplastic anemia].
Stamatović D; Balint B; Todorić-Zivanović B; Marjanović S; Lakić-Trajković Z; Malesević M
Vojnosanit Pregl; 2000; 57(5):95-8. PubMed ID: 11213682
[TBL] [Abstract][Full Text] [Related]
18. Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team.
Doney K; Leisenring W; Storb R; Appelbaum FR
Ann Intern Med; 1997 Jan; 126(2):107-15. PubMed ID: 9005744
[TBL] [Abstract][Full Text] [Related]
19. Antithymocyte immunoglobulin in severe aplastic anemia and bone marrow transplantation.
Colby C; Stoukides CA; Spitzer TR
Ann Pharmacother; 1996 Oct; 30(10):1164-74. PubMed ID: 8893124
[TBL] [Abstract][Full Text] [Related]
20. Making therapeutic decisions in adults with aplastic anemia.
Marsh J
Hematology Am Soc Hematol Educ Program; 2006; ():78-85. PubMed ID: 17124044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]